<mods xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://www.loc.gov/mods/v3" version="3.3" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-3.xsd"><id>2932984</id><setSpec>journal_article</setSpec><setSpec>doc-type:article</setSpec><setSpec>ddc:540</setSpec><setSpec>journal_articleFtxt</setSpec><setSpec>open_access</setSpec>

<genre>article</genre>

<titleInfo><title>In Vivo Antitumor Activity of a Novel Acetazolamide-Cryptophycin Conjugate for the Treatment of Renal Cell Carcinomas</title></titleInfo>


<note type="publicationStatus">published</note>


<note type="qualityControlled">yes</note>

<name type="personal">
  <namePart type="given">Samuele</namePart>
  <namePart type="family">Cazzamalli</namePart>
  <role><roleTerm type="text">author</roleTerm> </role></name>
<name type="personal">
  <namePart type="given">Eduard</namePart>
  <namePart type="family">Figueras Agustí</namePart>
  <role><roleTerm type="text">author</roleTerm> </role><identifier type="local">70995989</identifier></name>
<name type="personal">
  <namePart type="given">Lilla</namePart>
  <namePart type="family">Petho</namePart>
  <role><roleTerm type="text">author</roleTerm> </role></name>
<name type="personal">
  <namePart type="given">Adina Noémi</namePart>
  <namePart type="family">Borbély</namePart>
  <role><roleTerm type="text">author</roleTerm> </role><identifier type="local">70994745</identifier></name>
<name type="personal">
  <namePart type="given">Christian</namePart>
  <namePart type="family">Steinkuhler</namePart>
  <role><roleTerm type="text">author</roleTerm> </role></name>
<name type="personal">
  <namePart type="given">Dario</namePart>
  <namePart type="family">Neri</namePart>
  <role><roleTerm type="text">author</roleTerm> </role></name>
<name type="personal">
  <namePart type="given">Norbert</namePart>
  <namePart type="family">Sewald</namePart>
  <role><roleTerm type="text">author</roleTerm> </role><identifier type="local">20281</identifier><description xsi:type="identifierDefinition" type="orcid">0000-0002-0309-2655</description></name>







<name type="corporate">
  <namePart/>
  <identifier type="local">17977</identifier>
  <role>
    <roleTerm type="text">department</roleTerm>
  </role>
</name>








<abstract lang="eng">Traditional chemotherapeutics used in cancer therapy do not preferentially accumulate in tumor tissues. The conjugation to delivery vehicles like antibodies or small molecules has been proposed as a strategy to increase the tumor uptake and improve the therapeutic window of these drugs. Here, we report the synthesis and the biological evaluation of a novel small molecule-drug conjugate (SMDC) comprising a high-affinity bidentate acetazolamide derivative, targeting carbonic anhydrase IX (CAIX), and cryptophycin, a potent microtubule destabilizer. The biological activity of the novel SMDC was evaluated in vitro, measuring binding to the CAIX antigen by surface plasmon resonance and cytotoxicity against SKRC-52 cells. In vivo studies showed a delayed growth of tumors in nude mice bearing SKRC-52 renal cell carcinomas.</abstract>

<relatedItem type="constituent">
  <location>
    <url displayLabel="acsomega.8b02350.pdf">https://pub.uni-bielefeld.de/download/2932984/2955479/acsomega.8b02350.pdf</url>
  </location>
  <physicalDescription><internetMediaType>application/pdf</internetMediaType></physicalDescription>
  <accessCondition type="restrictionOnAccess">no</accessCondition>
</relatedItem>
<originInfo><publisher>AMER CHEMICAL SOC</publisher><dateIssued encoding="w3cdtf">2018</dateIssued>
</originInfo>
<language><languageTerm authority="iso639-2b" type="code">eng</languageTerm>
</language>



<relatedItem type="host"><titleInfo><title>ACS Omega</title></titleInfo>
  <identifier type="issn">2470-1343</identifier>
  <identifier type="MEDLINE">30533574</identifier>
  <identifier type="ISI">000451992500020</identifier><identifier type="urn">urn:nbn:de:0070-pub-29329842</identifier><identifier type="doi">10.1021/acsomega.8b02350</identifier>
<part><detail type="volume"><number>3</number></detail><detail type="issue"><number>11</number></detail><extent unit="pages">14726-14731</extent>
</part>
</relatedItem>


<extension>
<bibliographicCitation>
<lncs> Cazzamalli, S., Figueras Agustí, E., Petho, L., Borbély, A.N., Steinkuhler, C., Neri, D., Sewald, N.: In Vivo Antitumor Activity of a Novel Acetazolamide-Cryptophycin Conjugate for the Treatment of Renal Cell Carcinomas. ACS Omega. 3, 14726-14731 (2018).</lncs>
<chicago>&lt;div style="text-indent:-25px; padding-left:25px;padding-bottom:0px;"&gt;Cazzamalli, Samuele, Figueras Agustí, Eduard, Petho, Lilla, Borbély, Adina Noémi, Steinkuhler, Christian, Neri, Dario, and Sewald, Norbert. 2018. “In Vivo Antitumor Activity of a Novel Acetazolamide-Cryptophycin Conjugate for the Treatment of Renal Cell Carcinomas”. &lt;em&gt;ACS Omega&lt;/em&gt; 3 (11): 14726-14731.&lt;/div&gt;</chicago>
<mla>Cazzamalli, Samuele, Figueras Agustí, Eduard, Petho, Lilla, Borbély, Adina Noémi, Steinkuhler, Christian, Neri, Dario, and Sewald, Norbert. “In Vivo Antitumor Activity of a Novel Acetazolamide-Cryptophycin Conjugate for the Treatment of Renal Cell Carcinomas”. &lt;em&gt;ACS Omega&lt;/em&gt; 3.11 (2018): 14726-14731.</mla>
<default>Cazzamalli S, Figueras Agustí E, Petho L, Borbély AN, Steinkuhler C, Neri D, Sewald N (2018) &lt;br /&gt;&lt;em&gt;ACS Omega&lt;/em&gt; 3(11): 14726-14731.</default>
<ama>Cazzamalli S, Figueras Agustí E, Petho L, et al. In Vivo Antitumor Activity of a Novel Acetazolamide-Cryptophycin Conjugate for the Treatment of Renal Cell Carcinomas. &lt;em&gt;ACS Omega&lt;/em&gt;. 2018;3(11):14726-14731.</ama>
<frontiers>Cazzamalli, S., Figueras Agustí, E., Petho, L., Borbély, A. N., Steinkuhler, C., Neri, D., and Sewald, N. (2018). In Vivo Antitumor Activity of a Novel Acetazolamide-Cryptophycin Conjugate for the Treatment of Renal Cell Carcinomas. &lt;em&gt;ACS Omega&lt;/em&gt; 3, 14726-14731.</frontiers>
<dgps>&lt;div style="text-indent:-25px; padding-left:25px;padding-bottom:0px;"&gt;Cazzamalli, S., Figueras Agustí, E., Petho, L., Borbély, A.N., Steinkuhler, C., Neri, D. &amp;amp; Sewald, N. (2018). In Vivo Antitumor Activity of a Novel Acetazolamide-Cryptophycin Conjugate for the Treatment of Renal Cell Carcinomas. &lt;em&gt;ACS Omega&lt;/em&gt;, &lt;em&gt;3&lt;/em&gt;(11), 14726-14731. AMER CHEMICAL SOC. doi:10.1021/acsomega.8b02350.&lt;/div&gt;</dgps>
<apa>Cazzamalli, S., Figueras Agustí, E., Petho, L., Borbély, A. N., Steinkuhler, C., Neri, D., &amp;amp; Sewald, N. (2018). In Vivo Antitumor Activity of a Novel Acetazolamide-Cryptophycin Conjugate for the Treatment of Renal Cell Carcinomas. &lt;em&gt;ACS Omega&lt;/em&gt;, &lt;em&gt;3&lt;/em&gt;(11), 14726-14731. &lt;a href="https://doi.org/10.1021/acsomega.8b02350" target="_blank"&gt;https://doi.org/10.1021/acsomega.8b02350&lt;/a&gt;</apa>
<ieee> S. Cazzamalli, et al., “In Vivo Antitumor Activity of a Novel Acetazolamide-Cryptophycin Conjugate for the Treatment of Renal Cell Carcinomas”, &lt;em&gt;ACS Omega&lt;/em&gt;,  vol. 3, 2018,  pp. 14726-14731.</ieee>
<wels>Cazzamalli, S.; Figueras Agustí, E.; Petho, L.; Borbély, A. N.; Steinkuhler, C.; Neri, D.; Sewald, N. (2018): In Vivo Antitumor Activity of a Novel Acetazolamide-Cryptophycin Conjugate for the Treatment of Renal Cell Carcinomas &lt;em&gt;ACS Omega&lt;/em&gt;,3:(11): 14726-14731.</wels>
<bio1>Cazzamalli S, Figueras Agustí E, Petho L, Borbély AN, Steinkuhler C, Neri D, Sewald N (2018) &lt;br /&gt;In Vivo Antitumor Activity of a Novel Acetazolamide-Cryptophycin Conjugate for the Treatment of Renal Cell Carcinomas.&lt;br /&gt;ACS Omega 3(11): 14726-14731.</bio1>
<apa_indent>&lt;div style="text-indent:-25px; padding-left:25px;padding-bottom:0px;"&gt;Cazzamalli, S., Figueras Agustí, E., Petho, L., Borbély, A. N., Steinkuhler, C., Neri, D., &amp;amp; Sewald, N. (2018). In Vivo Antitumor Activity of a Novel Acetazolamide-Cryptophycin Conjugate for the Treatment of Renal Cell Carcinomas. &lt;em&gt;ACS Omega&lt;/em&gt;, &lt;em&gt;3&lt;/em&gt;(11), 14726-14731. &lt;a href="https://doi.org/10.1021/acsomega.8b02350" target="_blank"&gt;https://doi.org/10.1021/acsomega.8b02350&lt;/a&gt;&lt;/div&gt;</apa_indent>
<harvard1>Cazzamalli, S., et al., 2018. In Vivo Antitumor Activity of a Novel Acetazolamide-Cryptophycin Conjugate for the Treatment of Renal Cell Carcinomas. &lt;em&gt;ACS Omega&lt;/em&gt;, 3(11), p 14726-14731.</harvard1>
<angewandte-chemie>S.  Cazzamalli, E.  Figueras Agustí, L.  Petho, A. N.  Borbély, C.  Steinkuhler, D.  Neri, and N.  Sewald, “In Vivo Antitumor Activity of a Novel Acetazolamide-Cryptophycin Conjugate for the Treatment of Renal Cell Carcinomas”, &lt;em&gt;ACS Omega&lt;/em&gt;, &lt;strong&gt;2018&lt;/strong&gt;, &lt;em&gt;3&lt;/em&gt;, 14726-14731.</angewandte-chemie>
</bibliographicCitation>
</extension>
<recordInfo><recordIdentifier>2932984</recordIdentifier><recordCreationDate encoding="w3cdtf">2019-01-09T08:08:30Z</recordCreationDate><recordChangeDate encoding="w3cdtf">2021-06-10T06:13:36Z</recordChangeDate>
</recordInfo>
</mods>